Transcutaneous vagus nerve stimulation attenuates autoantibody-mediated cardiovagal dysfunction and inflammation in a rabbit model of postural tachycardia syndrome

Jielin Deng(Suizhou Central Hospital), Xichun Yu(University of Oklahoma Health Sciences Center), Stavros Stavrakis(University of Oklahoma Health Sciences Center), Hongliang Li(Boston University), Yankai Guo(Xinjiang Medical University), H. R. A. Fischer(University of Oklahoma Health Sciences Center), Gege Zhang(University of Oklahoma Health Sciences Center)
Journal of Interventional Cardiac Electrophysiology
February 4, 2022
10.1007/s10840-022-01144-w
Cited by 14

Related Papers

Low-Level Transcutaneous Electrical Vagus Nerve Stimulation Suppresses Atrial Fibrillation
|Journal of the American College of Cardiology|2015|327
TREAT AF (Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation)
|JACC. Clinical electrophysiology|2020|236
Cardiac myosin-Th17 responses promote heart failure in human myocarditis
|JCI Insight|2016|226
Catheter Ablation Versus Medical Therapy for Atrial Fibrillation
|Circulation Arrhythmia and Electrophysiology|2019|226
Low-level transcutaneous electrical stimulation of the auricular branch of the vagus nerve: A noninvasive approach to treat the initial phase of atrial fibrillation
|Heart Rhythm|2012|150